At one year following commercial launch, Intellijoint Surgical's intellijoint HIP® has been used in >1,000 total hip replacements throughout Australia, Canada and the U.S. The company plans to expand to new markets during 2017.
intellijoint HIP provides 3D mini-optical navigation. Used within the sterile field, the system addresses instability, hip dislocation and leg length discrepancy and is compatible with the majority of implant vendors. Within 1Q17, Intellijoint received FDA 510(k) clearance to market the device for use in the anterior surgical approach.
Source: Intellijoint Surgical Inc.; ORTHOWORLD Inc.